Kovack Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Kovack Advisors's ABBV Position: Q3 2026 in Review
Kovack Advisors increased its AbbVie (ABBV) stake by 5.8% in Q3 2026, buying an estimated $335K and bringing the position to 23,686 shares worth $6.17M. The position accounts for 0.26% of the portfolio, ranked #66.
Kovack Advisors first reported a position in ABBV in Q3 2015 and has held it in 44 quarters since. The position peaked at $7.06M in Q4 2025. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Kovack Advisors held 23,686 shares of AbbVie worth $6.17M as of Q3 2026.
- Kovack Advisors bought 1,306 AbbVie shares in Q3 2026, an estimated $335K.
- AbbVie made up 0.26% of Kovack Advisors's portfolio in Q3 2026, its #66 holding.
- Kovack Advisors first reported a position in AbbVie in Q3 2015 and has held it in 44 quarters since.
- Kovack Advisors's AbbVie position peaked at $7.06M in Q4 2025.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.